Royce & Associates’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13,821
| Closed | -$51.6K | – | 917 |
|
|
2024
Q3 | $51.6K | Hold |
13,821
| – | – | ﹤0.01% | 857 |
|
|
2024
Q2 | $77.4K | Hold |
13,821
| – | – | ﹤0.01% | 859 |
|
|
2024
Q1 | $72.4K | Buy |
+13,821
| New | +$72.4K | ﹤0.01% | 866 |
|
|
2023
Q4 | – | Sell |
-50,548
| Closed | -$797K | – | 951 |
|
|
2023
Q3 | $797K | Sell |
50,548
-8,666
| -15% | -$137K | 0.01% | 770 |
|
|
2023
Q2 | $1.15M | Buy |
59,214
+11,582
| +24% | +$225K | 0.01% | 742 |
|
|
2023
Q1 | $1.35M | Buy |
47,632
+12,437
| +35% | +$353K | 0.01% | 730 |
|
|
2022
Q4 | $1.03M | Buy |
35,195
+11,320
| +47% | +$331K | 0.01% | 751 |
|
|
2022
Q3 | $631K | Sell |
23,875
-6,550
| -22% | -$173K | 0.01% | 792 |
|
|
2022
Q2 | $1.35M | Sell |
30,425
-6,197
| -17% | -$275K | 0.01% | 709 |
|
|
2022
Q1 | $1.81M | Buy |
36,622
+17,978
| +96% | +$890K | 0.02% | 728 |
|
|
2021
Q4 | $949K | Buy |
18,644
+1,964
| +12% | +$100K | 0.01% | 816 |
|
|
2021
Q3 | $930K | Buy |
16,680
+882
| +6% | +$49.2K | 0.01% | 827 |
|
|
2021
Q2 | $676K | Buy |
15,798
+742
| +5% | +$31.8K | ﹤0.01% | 889 |
|
|
2021
Q1 | $628K | Buy |
15,056
+2,402
| +19% | +$100K | ﹤0.01% | 899 |
|
|
2020
Q4 | $589K | Sell |
12,654
-65
| -0.5% | -$3.03K | ﹤0.01% | 869 |
|
|
2020
Q3 | $540K | Sell |
12,719
-25,046
| -66% | -$1.06M | 0.01% | 853 |
|
|
2020
Q2 | $1.81M | Sell |
37,765
-13,882
| -27% | -$666K | 0.02% | 685 |
|
|
2020
Q1 | $2.38M | Buy |
51,647
+1,661
| +3% | +$76.4K | 0.03% | 556 |
|
|
2019
Q4 | $3M | Sell |
49,986
-8,781
| -15% | -$528K | 0.03% | 611 |
|
|
2019
Q3 | $3.32M | Sell |
58,767
-8,866
| -13% | -$501K | 0.03% | 584 |
|
|
2019
Q2 | $3.77M | Buy |
67,633
+3,150
| +5% | +$175K | 0.03% | 562 |
|
|
2019
Q1 | $3.26M | Buy |
64,483
+27,344
| +74% | +$1.38M | 0.03% | 605 |
|
|
2018
Q4 | $1.5M | Sell |
37,139
-3,894
| -9% | -$157K | 0.01% | 801 |
|
|
2018
Q3 | $2.85M | Buy |
41,033
+758
| +2% | +$52.6K | 0.02% | 747 |
|
|
2018
Q2 | $3.05M | Sell |
40,275
-29,768
| -42% | -$2.25M | 0.02% | 734 |
|
|
2018
Q1 | $3.69M | Sell |
70,043
-21,291
| -23% | -$1.12M | 0.03% | 660 |
|
|
2017
Q4 | $4.88M | Buy |
91,334
+23,418
| +34% | +$1.25M | 0.03% | 594 |
|
|
2017
Q3 | $4.05M | Buy |
+67,916
| New | +$4.05M | 0.03% | 640 |
|